Molecular mechanisms underlying the effects of hypo- and hyper-prolactinemia on spermatogenesis and fertility in male rats

被引:0
作者
Raut, Sanketa [1 ]
Khambata, Kushaan [2 ]
Singh, Dipty [1 ]
Balasinor, Nafisa Huseni [1 ]
机构
[1] ICMR Natl Inst Res Reprod & Child Hlth, Dept Neuroendocrinol, Jehangir Merwanji St, Mumbai 400012, India
[2] ICMR Natl Inst Res Reprod & Child Hlth, Dept Gamete Immunobiol, Mumbai, India
关键词
Hypoprolactinemia; Hyperprolactinemia; Spermatogenesis; Testes; RNA-Seq; Male fertility; RECEPTOR EXPRESSION; HYPERPROLACTINEMIA; MEN; HYPOPROLACTINEMIA; CABERGOLINE; LOCALIZATION; ACTIVATION; ESTROGEN; RECOVERY; QUALITY;
D O I
10.1007/s40618-024-02471-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PurposeHypo- and hyper-prolactinemia have deleterious effects on male reproduction, yet there is a dearth of information regarding the underlying mechanisms. The aim of this study was to delineate the molecular mechanisms by which hypo- and hyper-prolactinemia affects spermatogenesis and fertility in male rats.MethodsIn vivo male rat models for hypo- and hyper-prolactinemia were established using dopamine receptor agonist, Bromocriptine (Brm), and antagonist, Fluphenazine (Flu), respectively. Effects on fertility and spermatogenesis were assessed by studying pre- and post-implantation loss, litter size, sperm parameters, hormonal profile, testicular histology, testicular cell population, and testicular transcriptome in rats.ResultsTreatment with Brm and Flu for 60 days led to subfertility, which was indicated by an increase in pre- and post-implantation loss and decrease in litter size, when mated with control female rats. Decreased sperm count was observed after both treatments, whereas reduced sperm motility was noted in Flu group. Serum FSH was unaffected, and LH was decreased by Flu treatment. Testosterone was decreased in both the groups, whereas estradiol was decreased in the Flu group. An arrest in spermatogenic cycle beyond round spermatids was observed in the Flu group. Additionally, testicular apoptosis in germ cells, mostly spermatocytes of Stage IX-XIV was noted in both the groups. Further, testicular RNA-Seq analysis revealed a total of 1539 and 824 differentially expressed genes/DEGs in Brm and Flu, respectively (Sequence Read Archive/SRA Database accession number: PRJNA1150513). Gene ontology and pathway analysis of DEGs highlighted enrichment of steroid metabolic pathway and ribosomal biogenesis pathway. Hub genes identified from the DEGs were validated by qPCR and the results showed that Uba52, Rps27a, Rpl23, Rps5, Rps16 were significantly down-regulated by Brm, whereas Rps27a, Rps29, Rps15, Rps27, Faul1 were significantly down-regulated by Flu.ConclusionHypo- and hyper-prolactinemia leads to subfertility and decreased sperm parameters possibly through an effect on steroid metabolism and ribosomal biogenesis pathway. Therefore, maintaining prolactin levels in physiological range is crucial.
引用
收藏
页码:743 / 756
页数:14
相关论文
共 52 条
  • [1] Prevalence of Hyperprolactinemia and Clinically Apparent Prolactinomas in Men Undergoing Fertility Evaluation
    Ambulkar, Siddhant S.
    Darves-Bornoz, Anne L.
    Fantus, Richard J.
    Wren, James
    Bennett, Nelson E.
    Halpern, Joshua A.
    Brannigan, Robert E.
    [J]. UROLOGY, 2022, 159 : 114 - 119
  • [2] Differential Genes Expression between Fertile and Infertile Spermatozoa Revealed by Transcriptome Analysis
    Bansal, Sandeep Kumar
    Gupta, Nishi
    Sankhwar, Satya Narayan
    Rajender, Singh
    [J]. PLOS ONE, 2015, 10 (05):
  • [3] Activation of the tumor suppressor p53 upon impairment of ribosome biogenesis
    Bursac, Sladana
    Brdovcak, Maja Cokaric
    Donati, Giulio
    Volarevic, Sinisa
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2014, 1842 (06): : 817 - 830
  • [4] Outcome of cabergoline treatment in men with prolactinoma: Effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis
    Colao, A
    Vitale, G
    Cappabianca, P
    Briganti, F
    Ciccarelli, A
    De Rosa, M
    Zarrilli, S
    Lombardi, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) : 1704 - 1711
  • [5] Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia
    Colao, A
    Di Sarno, A
    Cappabianca, P
    Di Somma, C
    Pivonello, R
    Lombardi, G
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) : 2023 - 2033
  • [6] The prolactinoma
    Colao, Annamaria
    [J]. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (05) : 575 - 596
  • [7] Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual Dysfunction
    Corona, Giovanni
    Mannucci, Edoardo
    Jannini, Emmanuele A.
    Lotti, Francesco
    Ricca, Valdo
    Monami, Matteo
    Boddi, Valentina
    Bandini, Elisa
    Balercia, Giancarlo
    Forti, Gianni
    Maggi, Mario
    [J]. JOURNAL OF SEXUAL MEDICINE, 2009, 6 (05) : 1457 - 1466
  • [8] Hyperprolactinaemia in male infertility: Clinical case scenarios
    Dabbous, Zeinab
    Atkin, Stephen L.
    [J]. ARAB JOURNAL OF UROLOGY, 2018, 16 (01) : 44 - 52
  • [9] de Mattos K., 2023, Endocrines, V4, P573, DOI [10.3390/endocrines4030041, DOI 10.3390/ENDOCRINES4030041]
  • [10] The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males
    De Rosa, M
    Ciccarelli, A
    Zarrilli, S
    Guerra, E
    Gaccione, M
    Di Sarno, A
    Lombardi, G
    Colao, A
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 64 (03) : 307 - 313